TW201944905A - 用於促進能量代謝之組成物 - Google Patents
用於促進能量代謝之組成物 Download PDFInfo
- Publication number
- TW201944905A TW201944905A TW108109026A TW108109026A TW201944905A TW 201944905 A TW201944905 A TW 201944905A TW 108109026 A TW108109026 A TW 108109026A TW 108109026 A TW108109026 A TW 108109026A TW 201944905 A TW201944905 A TW 201944905A
- Authority
- TW
- Taiwan
- Prior art keywords
- saturated fatty
- composition
- chain saturated
- long chain
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 230000037149 energy metabolism Effects 0.000 title claims abstract description 46
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 27
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 14
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 239000003921 oil Substances 0.000 claims description 66
- 239000003925 fat Substances 0.000 claims description 63
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 57
- 235000013305 food Nutrition 0.000 claims description 53
- 230000001737 promoting effect Effects 0.000 claims description 32
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 12
- 230000037356 lipid metabolism Effects 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 235000014593 oils and fats Nutrition 0.000 claims description 7
- -1 beta-long chain saturated fatty acids Chemical class 0.000 claims description 6
- 125000005471 saturated fatty acid group Chemical group 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 59
- 235000019197 fats Nutrition 0.000 description 56
- 239000003795 chemical substances by application Substances 0.000 description 41
- 235000014113 dietary fatty acids Nutrition 0.000 description 15
- 229930195729 fatty acid Natural products 0.000 description 15
- 239000000194 fatty acid Substances 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 11
- 230000037406 food intake Effects 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 7
- 101150077457 ACOX1 gene Proteins 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000021056 liquid food Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 101150073133 Cpt1a gene Proteins 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000004129 fatty acid metabolism Effects 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 125000005457 triglyceride group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical compound CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 1
- 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000003407 synthetizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018051353A JP2019162055A (ja) | 2018-03-19 | 2018-03-19 | エネルギー代謝促進用組成物 |
| JP2018-051353 | 2018-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201944905A true TW201944905A (zh) | 2019-12-01 |
Family
ID=67987189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108109026A TW201944905A (zh) | 2018-03-19 | 2019-03-18 | 用於促進能量代謝之組成物 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2019162055A (ja) |
| CN (1) | CN111885927A (ja) |
| TW (1) | TW201944905A (ja) |
| WO (1) | WO2019181822A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024071138A1 (ja) * | 2022-09-27 | 2024-04-04 | 株式会社明治 | ミトコンドリア機能向上用組成物 |
| JP2025085534A (ja) * | 2023-11-24 | 2025-06-05 | 太陽油脂株式会社 | 糖代謝異常改善用油脂及び腸内環境改善用油脂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3120906B2 (ja) * | 1992-08-25 | 2000-12-25 | 雪印乳業株式会社 | β−パルミチン酸含有トリグリセリドの製造方法 |
| JPH07274825A (ja) * | 1994-03-31 | 1995-10-24 | Snow Brand Milk Prod Co Ltd | 易吸収性飲食品およびその製造法 |
| AU2004223980B2 (en) * | 2003-03-27 | 2010-11-11 | Suntory Holdings Limited | Lipid-improving agent and composition containing lipid-improving agent |
| IL158555A0 (en) * | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Human breast milk lipid mimetic as dietary supplement |
| JP2005320292A (ja) * | 2004-05-11 | 2005-11-17 | Kaneka Corp | ペルオキシソーム増殖剤応答性受容体リガンド剤 |
| TW200608896A (en) * | 2004-09-07 | 2006-03-16 | Multipower Entpr Corp | Breast milk simulated total nutritious food |
| RU2413430C2 (ru) * | 2005-04-27 | 2011-03-10 | Энзимотек Лтд. | Композиция жировой основы (варианты) и способ ее получения (варианты), композиция заменителя жира женского молока и способ ее получения (варианты), смесь для детского питания |
| US20100249248A1 (en) * | 2007-10-24 | 2010-09-30 | Suntory Holdings Limited | LIGAND AGENTS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs) |
| US8114461B2 (en) * | 2008-08-25 | 2012-02-14 | Brandeis University | Balanced sn-2 myristate-containing edible oil |
| EP2676551A1 (en) * | 2012-06-20 | 2013-12-25 | Benemilk Ltd | Feed enhancing energy metabolism in milk production |
| EP2845490A1 (en) * | 2013-09-05 | 2015-03-11 | Loders Croklaan B.V. | Fat composition for improved body fat distribution |
| JP2016202001A (ja) * | 2013-10-02 | 2016-12-08 | 株式会社カネカ | 油脂組成物 |
| US20160015068A1 (en) * | 2014-07-16 | 2016-01-21 | Mead Johnson Nutrition Company | Nutritional formulas containing oil blends and uses thereof |
-
2018
- 2018-03-19 JP JP2018051353A patent/JP2019162055A/ja active Pending
-
2019
- 2019-03-18 TW TW108109026A patent/TW201944905A/zh unknown
- 2019-03-18 WO PCT/JP2019/011067 patent/WO2019181822A1/ja not_active Ceased
- 2019-03-18 CN CN201980019035.0A patent/CN111885927A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019162055A (ja) | 2019-09-26 |
| WO2019181822A1 (ja) | 2019-09-26 |
| CN111885927A (zh) | 2020-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101411679B1 (ko) | 장내 세균총 생육 촉진 방법 및 지질 조성물 | |
| US6258846B1 (en) | Nutritional supplements | |
| JP2023181539A (ja) | プロバイオティクスを含む組成物、及びその使用方法 | |
| HK1042441A1 (zh) | Pufa增补剂 | |
| US20210260015A1 (en) | Composition for inhibiting fat accumulation | |
| CN107372985A (zh) | 一组适合糖尿病人群服食的以结晶果糖为甜味剂的果糖巧克力 | |
| TW201944905A (zh) | 用於促進能量代謝之組成物 | |
| JP2022159178A (ja) | 抗老化用組成物 | |
| CN102090453A (zh) | 瘦身美奶茶 | |
| TWI749050B (zh) | 包含選自瓜胺酸、白胺酸、半胱胺酸、牛磺酸、麩胺酸及天冬胺酸所成群組的１種或２種以上之胺基酸與中鏈脂肪酸及中鏈脂肪酸酯之任一者或兩者之組成物用於人攝取促進酮體生成之使用 | |
| HK40031488A (en) | Composition for accelerating energy metabolism | |
| JP2000302677A (ja) | カルニチン自己産生能改善作用を有する医薬および食品・飼料組成物 | |
| JP2021016375A (ja) | 有酸素性運動機能向上剤、有酸素性運動機能向上用食品組成物、有酸素性運動機能向上用医薬組成物 | |
| WO2024128185A1 (ja) | グレリン分泌促進用組成物 | |
| KR0144566B1 (ko) | 비피드균 증식 촉진제 | |
| WO2025013799A1 (ja) | 整腸剤 | |
| WO2024071138A1 (ja) | ミトコンドリア機能向上用組成物 | |
| KR20220000029A (ko) | 면역력 증강을 위한 건강 기능 식품 및 그 조성물 | |
| CN103315288B (zh) | 可清洁口腔牙齿的高热量咀嚼片 | |
| JP6629859B2 (ja) | 疲労軽減剤 | |
| JP2025161950A (ja) | プロピオン酸菌発酵物含有組成物 | |
| TW202500136A (zh) | 能量消耗促進劑 | |
| HK40120089A (zh) | 血管内皮功能改善用组合物 | |
| CN116322686A (zh) | 含有烟酰胺和维生素b6的组合物以及使用此类组合物来促进肌肉生长的方法 | |
| HK40003436A (en) | Composition for promoting ketone body formation |